A citation-based method for searching scientific literature

M Strupp, R Kalla, M Dichgans, T Freilinger, S Glasauer, T Brandt. Neurology 2004
Times Cited: 145







List of co-cited articles
878 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.
M Strupp, R Kalla, J Claassen, C Adrion, U Mansmann, T Klopstock, T Freilinger, H Neugebauer, R Spiegel, M Dichgans,[...]. Neurology 2011
109
41

The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia.
Karina Alviña, Kamran Khodakhah. J Neurosci 2010
111
39

Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
M Strupp, O Schüler, S Krafczyk, K Jahn, F Schautzer, U Büttner, T Brandt. Neurology 2003
153
36

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4.
R A Ophoff, G M Terwindt, M N Vergouwe, R van Eijk, P J Oefner, S M Hoffman, J E Lamerdin, H W Mohrenweiser, D E Bulman, M Ferrari,[...]. Cell 1996
34

Primary episodic ataxias: diagnosis, pathogenesis and treatment.
J C Jen, T D Graves, E J Hess, M G Hanna, R C Griggs, R W Baloh. Brain 2007
198
32

Clinical spectrum of episodic ataxia type 2.
J Jen, G W Kim, R W Baloh. Neurology 2004
177
29

4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus.
Roger Kalla, Stefan Glasauer, Ulrich Büttner, Thomas Brandt, Michael Strupp. Brain 2007
75
37

4-aminopyridine restores visual ocular motor function in upbeat nystagmus.
S Glasauer, R Kalla, U Büttner, M Strupp, T Brandt. J Neurol Neurosurg Psychiatry 2005
56
46

Hereditary paroxysmal ataxia: response to acetazolamide.
R C Griggs, R T Moxley, R A Lafrance, J McQuillen. Neurology 1978
159
24

Episodic ataxia type 2.
Michael Strupp, Andreas Zwergal, Thomas Brandt. Neurotherapeutics 2007
96
23

Potassium channel blockers inhibit the triggers of attacks in the calcium channel mouse mutant tottering.
Catherine J C Weisz, Robert S Raike, Luis E Soria-Jasso, Ellen J Hess. J Neurosci 2005
48
45


Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia.
Joy T Walter, Karina Alviña, Mary D Womack, Carolyn Chevez, Kamran Khodakhah. Nat Neurosci 2006
270
19


Downbeat nystagmus: aetiology and comorbidity in 117 patients.
J N Wagner, M Glaser, T Brandt, M Strupp. J Neurol Neurosurg Psychiatry 2008
94
18

Detection of floccular hypometabolism in downbeat nystagmus by fMRI.
R Kalla, A Deutschlander, K Hufner, T Stephan, K Jahn, S Glasauer, T Brandt, M Strupp. Neurology 2006
60
28

A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus--effects on slowphase eye velocity, postural stability, locomotion and symptoms.
Jens Claassen, Rainer Spiegel, Roger Kalla, Mary Faldon, Christopher Kennard, Chotipat Danchaivijitr, Stanislaw Bardins, Nicole Rettinger, Erich Schneider, Thomas Brandt,[...]. J Neurol Neurosurg Psychiatry 2013
48
33

Effects of dalfampridine on attacks in patients with episodic ataxia type 2: an observational study.
Jens Claassen, Julian Teufel, Roger Kalla, Rainer Spiegel, Michael Strupp. J Neurol 2013
21
76

4-aminopyridine and cerebellar gait: a retrospective case series.
Roman Schniepp, Max Wuehr, Maximilian Neuhaeusser, Ann Kathrin Benecke, Christine Adrion, Thomas Brandt, Michael Strupp, Klaus Jahn. J Neurol 2012
40
37

4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain.
R Kalla, S Glasauer, F Schautzer, N Lehnen, U Büttner, M Strupp, T Brandt. Neurology 2004
55
25

Methylprednisolone, valacyclovir, or the combination for vestibular neuritis.
Michael Strupp, Vera Carina Zingler, Viktor Arbusow, Daniel Niklas, Klaus Peter Maag, Marianne Dieterich, Sandra Bense, Diethilde Theil, Klaus Jahn, Thomas Brandt. N Engl J Med 2004
212
14

Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia.
A Escayg, M De Waard, D D Lee, D Bichet, P Wolf, T Mayer, J Johnston, R Baloh, T Sander, M H Meisler. Am J Hum Genet 2000
269
13

Aminopyridines for the treatment of cerebellar and ocular motor disorders.
Michael Strupp, Roger Kalla, Stefan Glasauer, Judith Wagner, Katharina Hüfner, Klaus Jahn, Thomas Brandt. Prog Brain Res 2008
36
36

Effects of acetyl-DL-leucine in patients with cerebellar ataxia: a case series.
Michael Strupp, Julian Teufel, Maximilian Habs, Regina Feuerecker, Carolin Muth, Bart P van de Warrenburg, Thomas Klopstock, Katharina Feil. J Neurol 2013
47
27

Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel.
A Jouvenceau, L H Eunson, A Spauschus, V Ramesh, S M Zuberi, D M Kullmann, M G Hanna. Lancet 2001
260
12

KCa channels as therapeutic targets in episodic ataxia type-2.
Karina Alviña, Kamran Khodakhah. J Neurosci 2010
72
16

Late-onset episodic ataxia type 2 due to an in-frame insertion in CACNA1A.
P Imbrici, L H Eunson, T D Graves, K P Bhatia, N H Wadia, D M Kullmann, M G Hanna. Neurology 2005
35
34

Consensus paper: management of degenerative cerebellar disorders.
W Ilg, A J Bastian, S Boesch, R G Burciu, P Celnik, J Claaßen, K Feil, R Kalla, I Miyai, W Nachbauer,[...]. Cerebellum 2014
88
13

Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures.
J C Jen, J Wan, T P Palos, B D Howard, R W Baloh. Neurology 2005
221
11

Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus.
Roger Kalla, Rainer Spiegel, Jens Claassen, Stanislavs Bardins, Ales Hahn, Erich Schneider, Nicole Rettinger, Stefan Glasauer, Thomas Brandt, Michael Strupp. J Neuroophthalmol 2011
28
39

Aminopyridines correct early dysfunction and delay neurodegeneration in a mouse model of spinocerebellar ataxia type 1.
Raphael Hourez, Laurent Servais, David Orduz, David Gall, Isabelle Millard, Alban de Kerchove d'Exaerde, Guy Cheron, Harry T Orr, Massimo Pandolfo, Serge N Schiffmann. J Neurosci 2011
86
12

Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis.
S R Schwid, M D Petrie, M P McDermott, D S Tierney, D H Mason, A D Goodman. Neurology 1997
143
10

Absence epilepsy in tottering mutant mice is associated with calcium channel defects.
C F Fletcher, C M Lutz, T N O'Sullivan, J D Shaughnessy, R Hawkes, W N Frankel, N G Copeland, N A Jenkins. Cell 1996
583
10

Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia.
Paola Imbrici, Stephen L Jaffe, Louise H Eunson, Nicholas P Davies, Colin Herd, Robert Robertson, Dimitri M Kullmann, Michael G Hanna. Brain 2004
148
10

Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel.
O Zhuchenko, J Bailey, P Bonnen, T Ashizawa, D W Stockton, C Amos, W B Dobyns, S H Subramony, H Y Zoghbi, C C Lee. Nat Genet 1997
10

A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus.
L Averbuch-Heller, R J Tusa, L Fuhry, K G Rottach, G L Ganser, W Heide, U Büttner, R J Leigh. Ann Neurol 1997
134
10

Vestibular paroxysmia: diagnostic features and medical treatment.
K Hüfner, D Barresi, M Glaser, J Linn, C Adrion, U Mansmann, T Brandt, M Strupp. Neurology 2008
90
11

Long-term prophylactic treatment of attacks of vertigo in Menière's disease--comparison of a high with a low dosage of betahistine in an open trial.
Michael Strupp, Doreen Hupert, Claudia Frenzel, Judith Wagner, Ales Hahn, Klaus Jahn, Vera-Carina Zingler, Ulrich Mansmann, Thomas Brandt. Acta Otolaryngol 2008
66
15


Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p.
C Jodice, E Mantuano, L Veneziano, F Trettel, G Sabbadini, L Calandriello, A Francia, M Spadaro, F Pierelli, F Salvi,[...]. Hum Mol Genet 1997
212
10

The effect of 3,4-diaminopyridine on the patients with hereditary pure cerebellar ataxia.
Taiji Tsunemi, Kinya Ishikawa, Kei Tsukui, Takuro Sumi, Ken Kitamura, Hidehiro Mizusawa. J Neurol Sci 2010
20
50

Periodic vestibulocerebellar ataxia, an autosomal dominant ataxia with defective smooth pursuit, is genetically distinct from other autosomal dominant ataxias.
K F Damji, R R Allingham, S C Pollock, K Small, K E Lewis, J M Stajich, L H Yamaoka, J M Vance, M A Pericak-Vance. Arch Neurol 1996
59
16

A new episodic ataxia syndrome with linkage to chromosome 19q13.
Kevin A Kerber, Joanna C Jen, Hane Lee, Stanley F Nelson, Robert W Baloh. Arch Neurol 2007
34
29

Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2.
Elide Mantuano, Silvia Romano, Liana Veneziano, Cinzia Gellera, Barbara Castellotti, Sara Caimi, Daniela Testa, Margherita Estienne, Giovanna Zorzi, Marianna Bugiani,[...]. J Neurol Sci 2010
48
20

Pharmacokinetics of an immediate-release oral formulation of Fampridine (4-aminopyridine) in normal subjects and patients with spinal cord injury.
K C Hayes, M A Katz, J G Devane, J T C Hsieh, D L Wolfe, P J Potter, A R Blight. J Clin Pharmacol 2003
56
16

Increased noise level of purkinje cell activities minimizes impact of their modulation during sensorimotor control.
F E Hoebeek, J S Stahl, A M van Alphen, M Schonewille, C Luo, M Rutteman, A M J M van den Maagdenberg, P C Molenaar, H H L M Goossens, M A Frens,[...]. Neuron 2005
107
9


Large CACNA1A deletion in a family with episodic ataxia type 2.
Florence Riant, Reda Mourtada, Pascale Saugier-Veber, Elisabeth Tournier-Lasserve. Arch Neurol 2008
30
30

Large scale calcium channel gene rearrangements in episodic ataxia and hemiplegic migraine: implications for diagnostic testing.
R W Labrum, S Rajakulendran, T D Graves, L H Eunson, R Bevan, M G Sweeney, S R Hammans, N Tubridy, T Britton, L J Carr,[...]. J Med Genet 2009
37
24

Potassium channel blocker 4-aminopyridine is effective in interictal cerebellar symptoms in episodic ataxia type 2--a video case report.
Matthias Löhle, Wiebke Schrempf, Martin Wolz, Heinz Reichmann, Alexander Storch. Mov Disord 2008
12
75


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.